Parents of children with rare neurological disorders have a lot to think about when it comes to clinical genetic testing (CGT). A recent study asked 101 parents about their thoughts on this topic. The children involved had conditions like cerebral palsy, epilepsy, and developmental delays. Most parents, around 82% to 91%, saw the positive sides of CGT. They believed...
A big change is happening for 23andMe. A court just gave the green light for the company to be sold to a nonprofit group. This group is led by Anne Wojcicki, who used to be the CEO. The sale is worth $305 million. This is not the first time 23andMe has been up for sale. Earlier, there was a $256 million offer from a pharmaceutical company, but that didn't go through....
Genetic research has become a hot topic in recent years. It is a field that holds immense potential for medical advancements. However, public opinion on this subject is not uniform. It is influenced by a variety of factors. One of the most significant factors is religion. This is according to a survey conducted in the United States. The survey involved nearly 5...
Genetic testing for cancer is a powerful tool that can spot cancer risks early. But, surprisingly, not many people are taking advantage of it. A recent investigation dug into why this is happening. It looked at how a person's role as a caregiver, their involvement in online support groups, and their gender might affect their decision to get tested. The study used a ...
Genetic testing has been a hot topic in health circles for years. However, not much thought has gone into how different communities view it. This is especially true for Latino groups. Researchers have looked at attitudes and clinical processes. Yet, they often miss out on using helpful theories. One key idea is behavioral intention. It's a strong sign of whether some...
Fragile X syndrome (FXS) is a condition that often leads to developmental delays, intellectual disabilities, and autism spectrum disorder. Since 2016, genetic testing for FXS has been part of Japan's national health insurance. Despite this, the number of FXS diagnoses remains surprisingly low. This raises an important question: how well do pediatricians in Japan unde...
Osteogenesis imperfecta (OI) is a rare genetic condition that affects the body's connective tissues, making bones unusually fragile. This condition is usually identified through clinical observations, but genetic testing can provide additional insights. In Romania, a group of nine patients with type I OI were studied between 2021 and 2024. These patients were seen a...
The world of genetic testing is not always as fair as it should be. A recent study looked into how often people at risk for ovarian cancer get the genetic tests they need. The National Comprehensive Cancer Network suggests that people with a family history of ovarian cancer should get tested for genetic mutations. This is because some people inherit a higher risk ...
Genetic testing for colorectal cancer (CRC) can reveal if a person has an inherited syndrome. This information is valuable, but it can also lead to tough decisions. Many people struggle with whether or not to get tested. This is a problem, especially with more people wanting genetic tests and not enough genetic counselors to help. So, how can we make sure people get ...
Medicare has rules for covering gene tests. These rules are called National Coverage Determinations. They were first put in place in 2018 and then changed in 2020. These rules are for a type of genetic testing known as next-generation sequencing. This testing looks at many genes at once. It can help find out if someone has a higher chance of getting cancer. It can al...